Salwa Almefareh: Bringing Life-Changing Haemophilia Care to Patients Worldwide
Salwa Almefareh, Regulatory Affairs Specialist at Roche Middle East, Mohamed Naser Al-Hajery and Sons Ltd., shared a post on LinkedIn:
“True innovation in haemophilia A extends beyond scientific discovery, it is realized when innovation reaches the patients who need it most.
At Roche, we believe meaningful progress is driven by strong partnerships and a shared commitment to improving global health.
Our long-term support of the World Federation of Hemophilia WFH Humanitarian Aid Program reflects this commitment, helping expand access to care for people living with inherited bleeding disorders in low- and middle-income countries.
By working together across the healthcare ecosystem, we can help reduce disparities in care, strengthen health systems, and create a future where more people with haemophilia have the opportunity to receive timely, life-changing treatment.
Learn how collaboration continues to shape the future of haemophilia care.”
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 12:17Exploring Endothelial Cells, Genetic Fate Mapping, and Revascularization – ISTH
-
Oct 16, 2026, 10:07Habib Bennaceur: Building a Stronger Care Pathway for Sickle Cell Disease in India
-
Oct 16, 2026, 09:59Tareq Abadl: A Simple Guide to Blood Collection Tubes
-
Oct 16, 2026, 09:50Mona Alfaraj: Distinguishing HCL from SMZL in Bone Marrow
-
Oct 16, 2026, 09:44New International Consensus on Covert Brain Infarction – International Journal of Stroke
-
Oct 16, 2026, 06:17Neha Rastogi Panda: Precision Diagnosis and Organ Preservation in Splenic Abscess
-
Oct 16, 2026, 05:53Alejandro González Veliz: Looking Beyond Coronary Anatomy to Understand Ischemia
-
Oct 16, 2026, 04:16Asmaa M. Gouda: Advancing Blood Bank Leadership at Alexandria University Hospitals
-
Oct 16, 2026, 03:52Saja Al-Zamili: Minimally Invasive Hematoma Evacuation in Intracerebral Hemorrhage